MedDataX Logo

Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management

NCT ID: NCT02344082

Last Updated: 2018-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC).

Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Telemedicine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of Care

The control arm will receive face-to-face pharmacy clinic visits per usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention Arm

The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

Group Type ACTIVE_COMPARATOR

Telemedicine

Intervention Type OTHER

The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telemedicine

The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients with a primary care provider at JHOC or EMBC
* Patients have seen primary care provider within last 6 months
* Patients with hemoglobin A1c greater than 9%

Exclusion Criteria

* Patients \<18 years of age
* Patients with previously established care with JHH ambulatory care pharmacist
* Patients with communication barriers who do not have a caregiver
* Patients with new diagnosis of diabetes
* Patients who are pregnant or planning to become pregnant during the time of the study
* Patients followed by Endocrinology or Diabetes Center
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johns Hopkins University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1819

Identifier Type: OTHER

Identifier Source: secondary_id

IRB00051947

Identifier Type: -

Identifier Source: org_study_id